Why is Akums Drugs falling/rising?

As of 29-Sep, Akums Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 444.00, which reflects a decrease of 2.35 (-0.53%). The stock has been underperforming, having fallen for the last six consecutive days, resulting in a total decline of 6.84% during this period. Additionally, it is trading below all its moving averages, indicating a bearish trend. Over the past year, the stock has generated a significant return of -46.81%, while its profits have risen dramatically by 1362%. Despite a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.3, the company faces challenges such as poor long-term growth and disappointing quarterly results, which contribute to the negative sentiment surrounding its stock.
In the broader market context, Akums Drugs has underperformed compared to the Sensex, which has seen a decline of only 2.18% over the past week, while Akums has dropped by 6.77%. This stark contrast highlights the stock's struggles relative to the market. Furthermore, the company's flat results in recent quarters, including a significant drop in profit after tax and the highest interest expenses recorded, suggest ongoing operational difficulties. These factors, combined with the stock's poor performance over the last year and its inability to keep pace with the broader market, reinforce the bearish outlook for Akums Drugs.